CAPTRUST Financial Advisors’s Alignment Healthcare ALHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$301K Buy
12,642
+1,648
+15% +$31.6K ﹤0.01% 2596
2026
Q1
$194K Buy
+10,994
New +$221K ﹤0.01% 2695
2022
Q3
Sell
-227
Closed -$3K 2125
2022
Q2
$3K Hold
227
﹤0.01% 4276
2022
Q1
$3K Buy
+227
New +$2.04K ﹤0.01% 4333
2021
Q3
Sell
-157
Closed -$4K 4623
2021
Q2
$4K Buy
+157
New +$3.82K ﹤0.01% 3926

Other funds holding ALHC

CAPTRUST Financial Advisors's ALHC Position: Q2 2026 in Review

CAPTRUST Financial Advisors increased its Alignment Healthcare (ALHC) stake by 15% in Q2 2026, buying an estimated $31.6K and bringing the position to 12,642 shares worth $301K. The position accounts for ﹤0.01% of the portfolio, ranked #2596.

CAPTRUST Financial Advisors first reported a position in ALHC in Q2 2021 and has held it in 5 quarters since. 324 funds tracked by Wall St. Rank hold ALHC as of Q2 2026.

  • CAPTRUST Financial Advisors held 12,642 shares of Alignment Healthcare worth $301K as of Q2 2026.
  • CAPTRUST Financial Advisors bought 1,648 Alignment Healthcare shares in Q2 2026, an estimated $31.6K.
  • Alignment Healthcare made up ﹤0.01% of CAPTRUST Financial Advisors's portfolio in Q2 2026, its #2596 holding.
  • CAPTRUST Financial Advisors first reported a position in Alignment Healthcare in Q2 2021 and has held it in 5 quarters since.
  • 324 funds tracked by Wall St. Rank held Alignment Healthcare as of Q2 2026.

Based on CAPTRUST Financial Advisors's 13F filing for Q2 2026, filed 13 Aug 2026.